This article examines the current and expected impact of the pandemic on individuals with Alzheimer’s disease and related dementias (ADRD). These individuals are at high risk for COVID-19 and its associated morbidity and mortality.

In their article, the authors discuss and propose mitigation strategies for: the risk of COVID-19 infection and its associated morbidity and mortality for individuals with ADRD; the impact of COVID-19 on the diagnosis and clinical management of ADRD; consequences of societal responses to COVID-19 in different ADRD care settings; the effect of COVID-19 on caregivers and physicians of individuals with ADRD; mental hygiene, trauma, and stigma in the time of COVID-19; and the potential impact of COVID-19 on ADRD research.

Amid considerable uncertainty, they believe we may be able to prevent or reduce the harm of the COVID-19 pandemic and its consequences for individuals with ADRD and their caregivers.